Biologic and targeted therapeutics in vitiligo-Reference-Cited by-同舟云学术

Biologic and targeted therapeutics in vitiligo

Published:2022-02-09 Issue:1 Volume:22 Page:64-73
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Karagaiah Priyanka¹,Schwartz Robert A.²,Lotti Torello³⁴,Wollina Uwe⁵^ORCID,Grabbe Stephan⁶,Goldust Mohamad⁶^ORCID

Affiliation:

1. Department of Dermatology Bangalore Medical College and Research Institute Bangalore India

2. Department of Dermatology Rutgers New Jersey Medical School Newark New Jersey USA

3. Department of Dermatology University of Studies Guglielmo Marconi Rome Italy

4. Department of Dermatology and Communicable Diseases First Medical State University of Moscow I. M. Sechenev Ministry of Health Moscow Russia

5. Department of Dermatology and Allergology Städtisches Klinikum Dresden Academic Teaching Hospital of the Technical University of Dresden Dresden Germany

6. Department of Dermatology University Medical Center of the Johannes Gutenberg University Mainz Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.14770

Reference51 articles.

1. Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci

2. Variant ofTYRand Autoimmunity Susceptibility Loci in Generalized Vitiligo

3. Aspirin induces Nrf2‐mediated transcriptional activation of haem oxygenase‐1 in protection of human melanocytes from H 2 O 2 ‐induced oxidative stress

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: A systematic review, from mechanisms of action to mono‐, combination and comparative therapies;Journal of Cosmetic Dermatology;2024-08-19

2. Implication of colloidal therapeutics in the treatment of vitiligo: Portray of signaling cascade, current drug-targets and preclinical and clinical evidences;Journal of Drug Delivery Science and Technology;2024-06

3. Assessment of serum granulysin and cathepsin-L levels in vitiligo patients;Revista da Associação Médica Brasileira;2024

4. Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics;Journal of Clinical Medicine;2023-12-04

5. Vitiligo. Novel Treatment Modalities. Small Molecule Inhibitors and Cytokine-Targeted Treatments;J BIOL REG HOMEOS AG;2023